FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release SyndromeRobert Q. Le, Richard Pazdur, Donna Przepiorka et al.|The Oncologist|2018Cited by 880